Oxygenta [OXYGENTAPH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Oxygenta Pharmaceutical Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Oxygenta Pharmaceutical Ltd. wins in 3 metrics, Sun Pharmaceutical Industries Ltd. wins in 15 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Oxygenta Pharmaceutical Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 444.32 36.73 Sun Pharmaceutical Industries Ltd.
Price-to-Book Ratio -5.50 5.15 Sun Pharmaceutical Industries Ltd.
Debt-to-Equity Ratio -1.99 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio 19.02 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA -15.15 23.61 Sun Pharmaceutical Industries Ltd.
Profit Margin (TTM) -15.47% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) -14.55% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) N/A 26.17% N/A
Return on Equity 38.69% 15.08% Oxygenta Pharmaceutical Ltd.
Return on Assets (TTM) -11.61% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-87.89M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return -45.31% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 1.87 7.05 Oxygenta Pharmaceutical Ltd.
Enterprise Value $2.82B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 2.50 6.66 Oxygenta Pharmaceutical Ltd.
Gross Profit Margin (TTM) -4.06% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $31 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $-4.72 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.52 0.11 Sun Pharmaceutical Industries Ltd.

Oxygenta Pharmaceutical Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

OXYGENTAPH
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Oxygenta Pharmaceutical Ltd.1.71%-5.41%-12.37%-0.30%-20.06%-7.05%
Sun Pharmaceutical Industries Ltd.-0.47%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Oxygenta Pharmaceutical Ltd.-45.31%60.31%375.14%380.79%624.83%225.39%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Oxygenta Pharmaceutical Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricOXYGENTAPHSUNPHARMA
Market Information
Market Cap i₹2.00B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,4323,903,142
90 Day Avg. Volume i7,9953,253,866
Last Close₹50.70₹1,780.10
52 Week Range₹45.30 - ₹133.50₹1,548.00 - ₹1,916.60
% from 52W High-62.02%-7.12%
All-Time High₹133.50 (Jun 09, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-62.02%-9.19%
Growth Metrics
Quarterly Revenue Growth0.02%0.14%
Quarterly Earnings GrowthN/A0.16%
Financial Health
Profit Margin (TTM) i-0.15%0.19%
Operating Margin (TTM) i-0.15%0.26%
Return on Equity (TTM) i0.39%0.15%
Debt to Equity (MRQ) i-1.996.68
Cash & Liquidity
Book Value per Share (MRQ)₹-9.89₹324.46
Cash per Share (MRQ)₹0.34₹115.87
Operating Cash Flow (TTM) i₹-61,057,000₹110.84B
Levered Free Cash Flow (TTM) i₹-96,826,000₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Oxygenta Pharmaceutical Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricOXYGENTAPH (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i444.3236.73
Forward P/E iN/A29.48
PEG Ratio i19.023.59
Price to Sales (TTM) i1.877.05
Price to Book (MRQ) i-5.505.15
Market Capitalization
Market Capitalization i₹2.00B₹3.88T
Enterprise Value i₹2.82B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i2.506.66
Enterprise to EBITDA i-15.1523.61
Risk & Other Metrics
Beta i0.520.11
Book Value per Share (MRQ) i₹-9.89₹324.46

Financial Statements Comparison: Oxygenta Pharmaceutical Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOXYGENTAPH (2025)SUNPHARMA (2025)
Revenue/Sales i1.09B520.41B
Cost of Goods Sold i1.08B121.98B
COGS % of Revenue i98.5%23.4%
Gross Profit i16.68M398.44B
Gross Margin i1.5%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i-103.50M125.81B
Operating Margin i-9.5%24.2%
EBITDA i-84.49M167.25B
EBITDA Margin i-7.7%32.1%
Pre-Tax Income i-115.53M137.52B
Pre-Tax Income % of Revenue i-10.6%26.4%
Income Tax i-18.70M27.72B
Income Tax % of Revenue i-1.7%5.3%
Net Income (Profit) i-96.83M109.65B
Profit Margin i-8.9%21.1%

Balance Sheet & Liquidity Metrics

MetricOXYGENTAPH (2025)SUNPHARMA (2025)
Cash & Equivalents i17,000102.69B
Total Current Assets i309.43M526.24B
Total Current Assets % of Revenue i28.3%101.1%
Total Current Liabilities i858.47M181.94B
Total Current Liabilities % of Revenue i78.5%35.0%
Long-Term Debt i215.22M3.58B
Long-Term Debt % of Revenue i19.7%0.7%
Total Shareholders Equity i-250.25M724.86B
Retained Earnings i-735.63M578.62B
Retained Earnings % of Revenue i-67.3%111.2%
Property, Plant & Equipment i14.36M100.36B

Cash Flow Statement Comparison

MetricOXYGENTAPH (2025)SUNPHARMA (2025)
Operating Cash Flow i-61.06M110.84B
Operating Cash Flow % of Revenue i-5.6%21.3%
Capital Expenditures i-112.72M-20.68B
Free Cash Flow i-87.89M119.44B
FCF Margin i-8.0%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricOXYGENTAPHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i36.98M2.40B
Float Shares i4.87M1.07B
% Held by Insiders i81.94%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i18.06%15.69%

Dividend Analysis & Yield Comparison: Oxygenta Pharmaceutical Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricOXYGENTAPHSUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026